| Financial Year |
March 31 2023 |
| Monetary Funds |
20,323,388.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,601,763.00 |
| Accounts Receivable |
205,942,248.49 |
| Advances to Suppliers |
18,989,408.94 |
| Other Receivables |
25,719,929.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
253,953,493.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,244,641.83 |
| Other Current Assets |
7,075,808.49 |
| Total Current Assets |
557,996,692.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
9,382,006.90 |
| Long-term Equity Investment |
186,281,440.83 |
| Investment Properties |
1,404,150.38 |
| Fixed Assetes |
274,919,998.01 |
| Under-construction Projects |
32,982,477.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,332,359.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
16,747,073.89 |
| Sub-Total of Non-Current Assets |
592,340,371.93 |
| Total Assets |
1,150,337,064.80 |
| Short-Term Loans |
289,270,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
92,908,173.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,335,025.28 |
| Taxes Payable |
16,411,636.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
83,681,667.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,048,048.80 |
| Sub-Total of Current Liabilities |
502,408,773.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,075,364.43 |
| Deferred Income Tax Liabilities |
1,308,838.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
70,552,500.19 |
| Total Liabilities |
572,961,274.14 |
| Paid-In Capital(Or Share Stock) |
484,219,953.00 |
| Capital Surplus |
193,527,782.39 |
| Surplus Reserve |
53,024,246.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-160,845,950.97 |
| Minority Stockholder's Interest |
684,075.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
576,691,715.17 |
| Owner's Equity（Stockholder's Equity） |
577,375,790.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,150,337,064.80 |
